Altered endocytosis of epidermal growth factor receptor in androgen receptor positve prostate cancer cell lines

Journal of Molecular Endocrinology

Volumn 38, Issue 1-2, 2007, Pages 51-66

  Bonaccorsi, Lorella ^a   Nosi, Daniele ^a   Muratori, Monica ^a   Formigli, Lucia ^a   Forti, Gianni ^a   Baldi, Elisabetta ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CAVEOLIN 1; CBL PROTEIN; CELL ANTIGEN; CLATHRIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; CELL LINE, TUMOR; ENDOCYTOSIS; HUMANS; MALE; PROSTATIC NEOPLASMS; RABBITS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

EID: 33847673078     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.02155     Document Type: Article

References (57)

1. Aguilar RC & Wendland B 2005 Endocytosis of membrane receptors: two pathways are better than one. PNAS 102 2679-2680.
2. Batch E, Bonaccorsi L & Forti G 2003 Androgen receptor: good guy or bad guy in prostate cancer invasion? Endocrinology 144 1653-1655.
3. Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, Signoretti S, Campbell KT, Sellers WR, Roberts TM, Loda M et al. 2004 Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells. Cancer Research 64 8867-8875.
4. Bonaccorsi L, Luconi M, Maggi M, Muratori M, Forti G, Serio M & Balch E 1997 Protein tyrosine kinase, mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating factor (PAF) in HEC-1A cells. Biochimica et Biophysica Acta 1355 155-166.
5. Bonaccorsi L, Carloni V, Muratori M, Salvadori A, Giannini A, Carini M, Serio M, Forti G & Baldi E 2000 Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype. Endocrinology 141 3172-3182.
6. Bonaccorsi L, Carloni V, Muratori M, Formigli L, Zecchi S, Forti G & Baldi E 2004a EGF receptor (EGER) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR). International Journal of Cancer 112 78-86.
7. Bonaccorsi L, Marchiani S, Muratori M, Forti G & Baldi E 2004b Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing P13 K/AKT activation. Journal of Cancer Research and Clinical Oncology 30 604-614.
8. Bonaccorsi L, Marchiani S, Ferruzzi P, Muratori M, Crescioli C, Forti G, Maggi M & Balch E 2006 Non-genomic effects of the androgen receptor and Vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells. Steroids 71 304-309.
9. Burke P, Schooler K & Wiley HS 2001 Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Molecular Biology of the Cell 12 1897-1910.
10. Chook YM, Gish GD, Kay CM, Pai EF & Pawson T 1996 The Grb2-mSos1 complex binds phosphopeptides with higher affinity than Grb2. Journal of Biological Chemistry 271 30472-30478.
11. Cinar B, Koeneman KS, Edlund M, Prins GS, Zhau HE & Chung LW 2001 Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line. Cancer Research 61 7310-7317.
12. Couet J, Sargiacomo M & Lisanti MP 1997 Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. Journal of Biological Chemistry 272 30429-30438.
13. Davis R, Jia D, Cinar B, Sikka SC, Moparty K, Zhau HE, Chung LW, Agrawal KC & Abdel-Mageed AB 2003 Functional androgen receptor confers sensitization of androgen-independent prostate cancer cells to anticancer therapy via caspase activation. Biochemical and Biophysical Research Communications 309 937-945.
14. Debes JD & Tindall DJ 2004 Mechanisms of androgen-refractory prostate cancer. New England Journal of Medicine 351 1488-1490.
15. Di Fiore PP & Gill GN 1999 Endocytosis and mitogenic signalling. Current Opinion in Cell Biology 11 483-488.
16. Di Lorenzo G, Tortora G, D'Armiento FP, De Rosa G, Staibano S, Autorino R, D'Armiento M, De Laurentiis M, De Placido S, Catalano G et al. 2002 Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. Clinical Cancer Research 8 3438-3444.
17. 2+/ cal-modulin-dependent kinase II phosphorylates the epidermal growth factor receptor on multiple sites in the cytoplasmic tail and serine 744 within the kinase domain to regulate signal generation. Journal of Biological Chemistry 274 16168-16173.
18. Festuccia C, Muzi P, Millimaggi D, Biordi L, Gravina GL, Speca S, Angelucci A, Dolo V, Vicentini C & Bologna M 2005 Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines. Endocrine Related Cancer 12 983-998.
19. Gaddipati JP, McLeod DG, Heidenberg HB, Sesterhenn IA, Finger MJ, Moul JW & Srivastava S 1994 Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Research 54 2861-2864.
20. Gucrini V, Sau D, Scaccianoce E, Rusmini P, Ciana P, Maggi A, Martini PG, Katzenellenbogen BS, Martini L, Moira M et al. 2005 The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. Cancer Research 65 5445-5453.
21. Guo L, Kozlosky CJ, Ericsson LH, Daniel TO, Cerretti DP & Johnson RS 2003 Studies of ligand-induced site-specific phosphorylation of epidermal growth factor receptor. Journal of the American Society for Mass Spectrometry 14 1022-1031.
22. Hatzoglou A, Kampa M, Kogia C, Charalampopoulos I, Theodoropoulos PA, Anezinis P, Dambaki C, Papakonstanti EA, Stathopoulos EN, Stournaras C et al. 2005 Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. Journal of Clinical Endocrinology and Metabolism 90 893-903.
23. Heinlein CA & Chang C 2004 Androgen receptor in prostate cancer. Endocrine Review 25 276-308.
24. Helin K & Beguinot L 1991 Internalization and down-regulation of the human epidermal growth factor receptor are regulated by the carboxyl-terminal tyrosines. Journal of Biological Chemistry 266 8363-8368.
25. Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J & Jenster G 2006 Evolution of the Androgen Receptor Pathway during Progression of Prostate Cancer. Cancer Research 66 5012-5020.
26. Huang F & Sorkin A 2005 Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis. Molecular Biology of the Cell 16 1268-1281.
27. Hyun TS & Ross TS 2004 HIP1: trafficking roles and regulation of tumorigenesis. Trends in Molecular Medicine 10 194-199.
28. Jiang X & Sorkin A 2003 Epidermal growth factor receptor internalization through clathrin-coated pits requires Cbl RING finger and proline-rich domains but not receptor polyubiquitylation. Traffic 4 529-543.
29. Johannessen LE, Pedersen NM, Pedersen KW, Madshus IH & Stang E 2006 Activation of the epidermal growth factor (EGF) receptor induces formation of EGF receptor- and Grb2-containing clathrin-coated pits. Molecular and Cellular Biology 26 389-401.
30. Khan EM, Heidinger JM, Levy M, Lisanti MP, Ravid T & Goldkorn T 2006 Epidermal Growth Factor Receptor Exposed to Oxidative Stress undergoes Src- and caveolin-1-dependent perinuclear trafficking. Journal of Biological Chemistry 281 14486-14493.
31. Le Roy C & Wrana JL 2005 Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nature Reviews Molecular Cell Biology 6 112-126.
32. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A et al. 1999 Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Molecular Cell 4 1029-1040.
33. McPherson PS, Kay BK & Hussain NK 2001 Signaling on the endocytic pathway. Traffic 2 375-384.
34. de Melker AA, van der Horst G & Borst J 2004 Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment. Journal of Biological Chemistry 279 55465-55473.
35. Mendoza N, Phillips GL, Silva J, Schwall R & Wickramasinghe D 2002 Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer. Cancer Research 62 5485-5488.
36. Mills IG, Gaughan L, Robson C, Ross T, McCracken S, Kelly J & Neal DE 2005 Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors. Journal of Cell Biology 170 191-200.
37. Nightingale J, Chaudhary KS, Abel PD, Stubbs AP, Romanska HM, Mitchell SE, Stamp GW & Lalani el-N 2003 Ligand activation of the androgen receptor downregulates E-cadherin-mediated cell adhesion and promotes apoptosis of prostatic cancer cells. Neoplasia 5 347-361.
38. Oksvold MP, Thien CB, Widerberg J, Chantry A, Huitfeldt HS & Langdon WY 2003 Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor. Oncogene 22 8509-8518.
39. Oosterhoff JK, Kuhne LC, Grootegoed JA & Blok LJ 2005 EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2. International Journal of Cancer 113 561-567.
40. Polo S, Pece S & Di Fiore PP 2004 Endocytosis and cancer. Current Opinion in Cell Biology 16 156-161.
41. Rabinovitz I, Gipson IK & Mercurio AM 2001 Traction forces mediated by alpha6beta4 integrin: implications for basement membrane organization and tumor invasion, Molecular Biology of the Cell 12 4030-4043.
42. Ravid T, Heidinger JM, Gee P, Khan EM & Goldkorn T 2004 c-Cbl-mediated ubiquitinylation is required for epidermal growth factor receptor exit from the early endosomes. Journal of Biological Chemistry 279 37153-37162.
43. Richardson DS, Lai AZ & Mulligan LM 2006 RET ligand-induced internalization and its consequence for downstream signaling. Oncogene 25 3206-3211.
44. Russell PJ, Bennett S & Stricker P 1998 Growth factor involvement in progression of prostate cancer. Clinical Chemistry 44 705-723.
45. Sigismund S, Woelk T, Puri C, Maspero E, Tacchetti C, Transidico P, Di Fiore PP & Polo S 2005 Clathrin-independent endocytosis of ubiquitinated cargos. PNAS 102 2760-2765.
46. Sorkin A 2001 Internalization of the epidermal growth factor receptor: role in signalling. Biochemical Society Transactions 29 480-484.
47. Sorkin A, Helin K, Waters CM, Carpenter G & Beguinot L 1992 Multiple autophosphorylation sites of the epidermal growth factor receptor are essential for receptor kinase activity and internalization. Contrasting significance of tyrosine 992 in the native and truncated receptors. Journal of Biological Chemistry 267 8672-8678.
48. Stang E, Blystad ED, Kazazic M, Bertelsen V, Brodahl T, Raiborg C, Stenmark H & Madshus IH 2004 Cbl-dependent ubiquitination is required for progression of ECT receptors into clathrin-coated pits. Molecular Biology of the Cell 15 3591-3604.
49. Tan J, Sharief Y, Hamil KG, Gregory CW, Zang DY, Sar M, Gumerlock PH, de Vere White RW, Pretlow TG, Harris SE et al. 1997 Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Molecular Endocrinology 11 450-459.
50. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R et al. 2005 Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 644-648.
51. Vieira AV, Lamaze C & Schmid SL 1996 Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274 2086-2089.
52. Wang Y, Pennock S, Chen X & Wang Z 2002 Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Molecular and Cellular Biology 22 7279-7290.
53. Wells A, Kassis J, Solava J, Turner T & Lauffenburger DA 2002 Growth factor-induced cell motility in tumor invasion. Acta Oncologica 41 124-130.
54. Whitacre DC, Chauhan S, Davis T, Gordon D, Cress AE & Miesfeld RL 2002 Androgen induction of in vitro prostate cell differentiation. Cell Growth, Diffferentiation 13 1-11.
55. Xue C, Wyckoff J, Liang E, Sidani M, Violini S, Tsai KL, Zhang ZY, Sahai E, Condeelis J & Segall JE 2006 Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Research 66 192-197.
56. Yamazaki T, Zaal K, Hailey D, Presley J, Lippincott-Schwartz J & Samelson LE 2002 Role of Grb2 in EGF-stimulated EGFR internalization. Journal of Cell Science 115 1791-1802.
57. Zhang W, Razani B, Altschuler Y, Bouzahzah B, Mostov KE, Pestell RG & Lisand MP 2000 Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1. Journal of Biological Chemistry 275 20717-20725.